Thrombolytic therapy--indications, advantages and disadvantages.
D001166:Arteriovenous Shunt, Surgical; D001777:Blood Coagulation / Q000187:drug effects*; D002536:Cerebral Arteries / Q000473:pathology; D003331:Coronary Vessels / Q000473:pathology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011317:Priapism / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000188:drug therapy; D012169:Retinal Vein / Q000473:pathology; D012171:Retinal Vessels / Q000473:pathology; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator